Novel method of progesterone delivery and affect thereof.

MYPI1994002436A0Inactive Publication Date: 1995-03-15COLUMBIA LABORATORIES (BERMUDA) LIMITED
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI1994002436
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
1993-09-15
Filing Date
1994-09-14
Publication Date
1995-03-15
Estimated Expiration
Not applicable · inactive patent
Patent Text Reader

Abstract

THE PRESENT INVENTION TEACHES THAT RELATIVELY LOW LEVELS OF SERUM PROGESTERONE, 1 TO 6 NG / ML, MAY BE USED TO PREVENT ENDOMETRIAL CANCER. THE VAGINAL DELIVERY OF PROGESTERONE USING A CROSS-LINKED POLYCARBOXYLIC POLYMER PRODUCES THIS LOW SERUM PROGESTERONE LEVEL WHILE ALSO PROVIDING THE FULL SECRETORY TRANSFORMATION OF THE ENDOMETRIUM, INDICATING THE EFFICACY OF THE PROGESTERONE. SUCH LOW LEVELS OF SERUM PROGESTERONE WILL DECREASE THE RISK OF BREAST CANCER EXPERIENCED BY WOMEN UNDERGOING HORMONE REPLACEMENT THERAPY ("HRT") AND MINIMIZE THE POTENTIAL OF OTHER UNDESIRABLE PROGESTERONE ASSOCIATED SIDE EFFECTS.
Need to check novelty before this filing date? Find Prior Art